Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TLR4 | O00206 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5918105 | 0.89 | CA1 (0.48) | KMT2ACA1CA2CA4TLR4 | |
| SCHEMBL27111874 | 0.83 | CA1 (0.40) | KMT2ACA1CA2CA4TLR4 | |
| SCHEMBL9965307 | 0.78 | CA1 (0.43) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL8864226 | 0.75 | KMT2A (0.35) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL10554006 | 0.74 | TLR4 (0.58) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL10553989 | 0.74 | TLR4 (0.58) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL2174072 | 0.71 | — | — | |
| SCHEMBL20547768 | 0.71 | — | — | |
| SCHEMBL16657572 | 0.71 | — | — | |
| SCHEMBL11465130 | 0.71 | CA1 (0.36) | KMT2ACA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016015014-A1 | NOVEL GLP-1 RECEPTOR MODULATORS | RECEPTOS, INC. (US) | 2016-01-28 | — | — | WO | disclosed |
| CN-102026950-B | Ethylenically unsaturated monomers comprising aliphatic and aromatic moieties | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-10-15 | — | — | CN | disclosed |
| CN-102026950-A | Ethylenically unsaturated monomers comprising aliphatic and aromatic moieties | DOW GLOBAL TECHNOLOGIES INC | 2011-04-20 | — | — | CN | disclosed |
| US-20110009560-A1 | ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-01-13 | — | — | US | disclosed |
| EP-2265564-A1 | ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES | Dow Global Technologies Inc. (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2009114466-A1 | ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-09-17 | — | — | WO | disclosed |
| EP-0612783-B1 | Cyanate resin composition and copper-clad laminate | SUMITOMO CHEMICAL CO (JP) | 1999-05-06 | — | — | EP | disclosed |
| US-5563237-A | INCLUDES A BISMALEIMIDE HARDENER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-10-08 | — | — | US | disclosed |
| EP-0612783-A1 | Cyanate resin composition and copper-clad laminate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009560-A1 | ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES | ELOB, ELOC, ELP1 | KMT2A 2032/4885CA1 4648/4885CA2 4768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.